Brain metastases are a very common manifestation of cancer that have historically been
approached as a single disease entity given the uniform association with poor clinical …

Brain metastases occur commonly in patients with advanced solid malignancies. Yet, less is
known about brain metastases than cancer-related entities of similar incidence. Advances in …

PURPOSE Conventional wisdom has rendered patients with brain metastases ineligible for
clinical trials for fear that poor survival could mask the benefit of otherwise promising …

The incidence of brain metastases has markedly increased in the past 20 years owing to
progress in the treatment of malignant solid tumours, earlier diagnosis by MRI and an …

Advances in chemotherapy and targeted therapies have improved survival in cancer
patients with an increase of the incidence of newly diagnosed brain metastases (BMs) …

Objectives: Common origins for brain metastases (BMs) are melanoma, lung, breast, and
renal cell cancers. BMs account for a large share of morbidity and mortality caused by these …

Brain metastasis (BM), the most common adult brain tumor, develops in 20% to 40% of
patients with late‐stage cancer and traditionally are associated with a poor prognosis. The …

Purpose Several studies evaluating stereotactic radiosurgery (SRS) for patients with> 4
brain metastases (BM) demonstrated similar outcomes after treatment of 1, 2 to 4, and 5 to …

Brain metastases (BrMs) are the most common form of brain tumors in adults and frequently
originate from lung and breast primary cancers. BrMs are associated with high mortality …

Background Historically, the prognosis for patients who have melanoma brain metastasis
(MBM) has been dismal. However, breakthroughs in targeted and immunotherapies have …